The skilled person - more knowledgeable than ever before

The concept of common general knowledge (CGK) occupies a more prominent position in the UK’s inventive step regime than it does in the European Patent Office's (EPO) problem-and-solution approach or the classic U.S. analysis in Graham v John Deere. The EPO and US approaches start by considering the prior art whereas the UK courts, following Pozzoli v BDMO, start with the skilled person and his or her CGK, putting that background knowledge in the spotlight and at the forefront of the mind of the skilled person for the later stages of the analysis.

The skilled person, memorably described by Jacob LJ in
Rockwater v Technip as "a nerd".

The courts have therefore tended to be careful in expanding out the scope of CGK, and for good reason: if the CGK is deemed to encompass more information, then the skilled person inherently knows correspondingly more about the background technology. Such a know-it-all will tend to regard fewer inventions as being inventive. So changing the CGK analysis inevitably changes the test for inventive step.

All of this helps explain why the IPKat is so exercised by yesterday’s decision in Teva UK Limited & another v AstraZeneca AB [2014] EWHC 2873 (Pat), decided by Mr Justice Sales in the Patents Court. The judge has held that the guidance from the traditional authorities on common general knowledge 

“needs to be adapted and kept appropriately up to date for the procedures for dissemination of scientific knowledge in the age of the internet and digital databases of journal articles”. 

Such an approach, he held, should include academic articles which “would not have been likely to have been read by the notional skilled person in the ordinary course of keeping himself up to date” but “would have been quickly identified by any person conducting a literature search and review into [the state of the art]”. As it happens, the articles which fell into the CGK under this updated analysis were also held not to have affected the outcome in any sense. Nevertheless, this Kat disagrees with the principles behind the judge’s analysis and wonders what readers make of it.

The case is not without other interest, and the IPKat may return to it in future posts: in particular the judgment contains an intriguing postscript detailing why a critical section had to be rewritten after it was circulated in draft form to the parties and was criticised by the patentee.

Background

AstraZeneca's product under the patent - Symbicort

Without getting too immersed in the details of the invention, all of which are explained with crystal clarity by Mr Justice Sales, the patent was for a second or subsequent medical use involving a known combination of drugs for treating asthma (formoterol and budesonide, since you ask). Asthma treatment typically has two parts: the patient takes one drug or drug combination via inhaler morning and night to keep the chronic condition in check (“maintenance treatment”), and then supplements this as necessary with another fast-acting drug to deal with acute asthma attacks that nevertheless occur (“relief treatment”).

The combination of formoterol and budesonide was known from the closest prior art document, which taught the use of this combination for maintenance treatment, but not for relief treatment. The claims require using this same combination as needed for relief from asthma attacks and also for maintenance treatment. The case turned on whether the CGK made it obvious to use the same combination for both aspects of asthma treatment, and following the Pozzoli approach, the judge had to decide on the content of the CGK.

I.                The conventional CGK

We can move quickly past the first two categories of CGK as they are uncontroversial. First there were classic items of CGK: statements in standard reference texts and in the guidelines on asthma care issued by the British Thoracic Society and US National Institutes of Health. Secondly, there were a few leading journal articles from The Lancet and the New England Journal of Medicine which addressed the treatment of asthma using combinations of β₂-agonists (such as formoterol) and steroids (such as budesonide). Neither side disputed that these articles represented CGK.

The standard reference work, a piece of good,
old-fashioned, CGK

II.             The next level of CGK

Then there was a third category of articles, for which the IPKat wishes to slow down and appeal for witnesses, without stopping on this occasion. The judge called these the “primary articles”, and they were described as academic articles which “were sufficiently prominent in the main academic journals in the field as to constitute part of the relevant CGK”. This is more of a conclusion than an explanation, but it’s the only reason given for the primary articles being part of the CGK.

The IPKat is unsure whether these primary articles provided the only basis for certain findings, most notably the finding that formoterol had a rapid onset of activity. The conventional CGK is not clearly mentioned as a source for that information, and without it, the skilled person might have struggled to arrive at the invention. It is also not clear on first reading whether AstraZeneca fought the inclusion of these articles in the CGK, and if so, what the competing arguments were or why Teva’s arguments were preferred.

Rather than weighing in on issues that may not be controversial or even relevant, the IPKat wonders if anyone involved in the case can clarify whether the inclusion of the primary articles changed the outcome of the case, and if so, whether their inclusion was contested.

III.          The controversial CGK

Finally, arriving at the documents whose inclusion is controversial (to this Kat at least), these were referred to by the judge as the “secondary articles”. They were described at [58] as a range of journal articles:

“which were not in leading journals in the field of respiratory medicine, and would not have been likely to have been read by the notional skilled person in the ordinary course of keeping himself up to date. On the other hand, these materials would have been quickly identified by any person conducting a literature search and review into the use of formoterol and ICS in relation to the treatment of asthma.”

The judge expanded at [60] on the reason for their inclusion:

“The authorities [unfortunately, none are cited; this is left as a general appeal to unstated authorities] indicate that CGK includes not just information directly in the mind of the notional skilled person, but such information as he would be able to locate by reference to well-known textbooks. This guidance needs to be adapted and kept appropriately up to date for the procedures for dissemination of scientific knowledge in the age of the internet and digital databases of journal articles. Searches of such databases are part and parcel of the routine sharing of information in the scientific community and are an ordinary research technique. In my view, if there is a sufficient basis (as here) in the background CGK relating to a particular issue to make it obvious to the unimaginative and uninventive skilled person that there is likely to be -- not merely a speculative possibility that there may be -- relevant published material bearing directly on that issue which would be identified by such a search, the relevant CGK will include material that would readily be identified by such a search.”

This does not sit comfortably with this Kat’s view of what the CGK should be based on. It’s all very well to say that times have changed and that information is shared differently in the digital age, but the nature of content published in different categories of source material (textbooks v seminal articles in the field v articles published in lesser journals that are not generally known to all practitioners) has surely not changed so much over time.

Indeed, the crux of whether or not a document represents the CGK has always (to this Kat’s mind) been less a function of where the information is located, and more a factual question of whether the information is of such a nature that it forms part of the skilled person’s toolkit – the basic knowledge against which such a person would inevitably evaluate any teaching, whether such knowledge is normally carried around in one’s head or instead is delegated to reference material which the skilled person can readily look up.

The judge’s approach suggests a different category of knowledge, at least as this Kat reads it, suggesting that when the skilled person reads a document, and that document makes it clear that there is more to learn, then he or she will be prompted to track down such additional information in the literature. As long as it is readily identifiable in that search, it appears that this should form part of the CGK.

The traditional approach

More fundamentally, the approach in Teva is stated as an updating of traditional guidance from the authorities, but one can question whether those authorities are characterised correctly. Admittedly, the IPKat does not know what authorities the judge was referring to when he said 

“The authorities indicate that CGK includes ... such information as [the skilled person] would be able to locate by reference to well-known textbooks”.  

It is this approach, the ability to locate information, that is built on and expanded for the digital age to encompass articles one can find in databases and which one knows or suspects must exist.

But rewind a little and consider if the CGK did in fact always include whatever you would be able to locate in a textbook? That question was addressed by Laddie J in Raychem Corp’s Patents [1997] EWHC 372 (Pat), where he took a more nuanced view:

“The common general knowledge is the technical background of the notional man in the art against which the prior art must be considered. This is not limited to material he has memorized and has at the front of his mind. It includes all that material in the field he is working in which he knows exists, which he would refer to as a matter of course if he cannot remember it and which he understands is generally regarded as sufficiently reliable to use as a foundation for further work or to help understand the pleaded prior art. This does not mean that everything on the shelf which is capable of being referred to without difficulty is common general knowledge nor does it mean that every word in a common text book is either. In the case of standard textbooks, it is likely that all or most of the main text will be common general knowledge. In many cases common general knowledge will include or be reflected in readily available trade literature which a man in the art would be expected to have at his elbow and regard as basic reliable information.”

If that statement of the law is correct, then it was never enough that information could be found in a text book. It also had to be material that the skilled person (a) knew existed, (b) would refer to as a matter of course, and (c) understood as being generally regarded as sufficiently reliable. In expanding CGK out as he has done, Mr Justice Sales’s test omits any requirement that the information should be something that the skilled person would refer to as a matter of course, and that he or she would understand as being generally regarded as a reliable foundation. Most research papers in journals, especially those journals that are not the flagship publications in a given field, fall far short of that level of authority and are nowhere near as reliable as a textbook.

Another criticism that can be levelled at this new approach is that, while scientific papers may be distributed and consulted differently than in the past, the nature of what they carry has not changed much. Indeed one could argue that the skilled person in any given field nowadays is probably less aware of the content of the average paper in his or her field than would have been the case decades ago (when the quantity of reading material was so much easier to keep up with). Scientific papers were considered specifically by the House of Lords in  General Tire v Firestone [1972] RPC 457, Sachs LJ quoting with approval from British Acoustic Films (53 RPC 221 at 250) where Luxmoore J said:

“A piece of particular knowledge as disclosed in a scientific paper does not become common general knowledge merely because it is widely read, and still less because it is widely circulated. Such a piece of knowledge only becomes general knowledge when it is generally known and accepted without question by the bulk of those who are engaged in the particular art; in other words, when it becomes part of their common stock of knowledge relating to the art.” [Sachs LJ commented that the phrase “accepted without question” was putting it a little high, and perhaps might be replaced by “generally regarded as a good basis for further action"]

Never one to pass by a pithy summation, Lord Justice Jacob also relied on the same passage in more recent times when giving his take on common general knowledge in Rockwater v Technip [2004] EWCA Civ381:, Having cheerily described the skilled person as "a nerd ... but not a complete android" (language which drew frosty disapproval from Lord Justice Pill in his concurring decision), Sir Robin then turned to the CGK:

“For brevity I do not quote [the passage from General Tire] in full – Luxmoore J's happy phrase "common stock of knowledge" conveys the flavour of what this notional man knows.”

The common thread from these authorities, which appears to be missing from the approach taken in Teva v AstraZeneca, is the requirement that knowledge needs to be generally known and accepted as uncontroversial, to form part of the common stock, before it can be regarded as part of the CGK. Information, even correct and relevant information, falls short of being CGK as long as it remains obscure and not widely known.

The documents which made it into the CGK under Mr Justice Sales’s test in Teva were, by contrast, unknown to the skilled person until he or she read something that suggested their existence. Their character was also far removed, it is suggested, from the types of information usually accepted as part of the common stock: they were papers describing various recent studies with, by and large, only tentative conclusions from their authors, those conclusions being in some cases mutually contradictory. As noted at the beginning, the judge found that whether or not these documents made it into the CGK did not affect the overall outcome. Nevertheless, the question arises whether the approach is correct for future cases.

So readers, what do you think? Is the test for inclusion of a scientific paper in the CGK ripe for an update? Are the authorities mentioned above by the IPKat outdated in the digital age? Should CGK depend on widespread acceptance, or should it turn on ease of access to a publication using modern tools?

Feline asthma here
CGK airport here
C., G. K. (ok, it's a stretch) wrote the Father Brown stories which you can read for free here